This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Tegafur-Uracil

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Tegafur-Uracil Means in Everyday Medical Language

Tegafur-Uracil is a chemotherapy drug made by combining two chemicals: tegafur and uracil. Tegafur is a prodrug, meaning it changes inside the body into an active cancer-fighting substance called 5-fluorouracil (5-FU). This substance works by interfering with cancer cells’ ability to grow and divide. Uracil helps increase the amount of 5-FU inside cancer cells by slowing its breakdown, which may improve how well the treatment works. Because of this combination, the drug is also called Ftorafur or UFT. These names all refer to the same or very similar drug combinations.

Why Tegafur-Uracil Can Matter in Cancer Care

Tegafur-Uracil is mainly used to treat bowel (colorectal) cancer and is approved in some countries, such as the UK, as a first treatment option for metastatic colorectal cancer when combined with folinic acid. It is taken by mouth, which some patients find more convenient and preferable compared to intravenous chemotherapy. The drug is also being studied for other cancers, including stomach, lung, breast, liver, and pancreatic cancers. Understanding this drug helps patients and caregivers recognize its role in treatment plans and discussions.

What Patients Might See or Hear About Tegafur-Uracil

You might come across the terms tegafur-uracil, Ftorafur, or UFT in medical reports, visit notes, treatment plans, or educational materials. Because these names are used interchangeably, it can be confusing. It’s important to ask your healthcare team what the term means for your specific care. The name alone does not tell you about your cancer type, stage, or prognosis. It is a drug name, not a diagnosis or treatment recommendation by itself.

Common Sources of Confusion and How to Read Tegafur-Uracil in Context

Tegafur-Uracil, Ftorafur, and UFT all refer to similar chemotherapy drugs, so seeing different names can be confusing. Also, because these are drug names, they do not provide information about your diagnosis or treatment plan by themselves. The safest approach is to ask your care team how this drug fits into your overall treatment. Don’t assume that seeing the name means a specific treatment is planned or that it applies to you without clarification.

Practical Questions to Ask Your Care Team

If you hear about tegafur-uracil or its related names, you might ask: What type of cancer is this drug used for? How does it work? Is it part of my treatment plan? What are the possible side effects? Are there other treatment options? These questions can help you feel more informed and involved in your care decisions.

How to Read the Term in Context and Safety Notes

This information is meant to help you understand what tegafur-uracil is and why it might be mentioned in your care. It does not replace advice from your healthcare team. Every patient’s situation is unique, so the best next step is to talk with your doctors or nurses about what this drug means for you personally. They can explain how it fits into your diagnosis, treatment, or follow-up care and answer any questions you have.

Sources

Public source information used for this glossary entry includes: